Chemistry: molecular biology and microbiology – Spore forming or isolating process
Patent
1991-11-25
1993-11-30
Lacey, David L.
Chemistry: molecular biology and microbiology
Spore forming or isolating process
5303873, 53038835, 5303879, 5303871, 5303913, 530327, C07K 1528, C07K 1500, C12P 2108, C12N 512
Patent
active
052664783
ABSTRACT:
Disclosed are monoclonal antibodies and related products which bind to the second variable region of HIV-1 gp120 and synthetic peptides and anti-idiotypic antibodies which induce endogenous production of antibodies with these same properties.
REFERENCES:
Waldmann et al. Science vol. 252 p. 1657, 1991.
Reichmann et al. Nature vol. 332 1988 p. 323.
Lambert Journal of Biological Chemistry vol. 260 No. 22, 12035, 1985.
Gosting et al. Journal of Clinical Micro-vol. 25 No. 5, 845 1987.
Kent et al. abstract 1991.
Stephans et al. abstract 1991.
Fung et al. abstract 1991.
Silvera et al. abstract 1991.
Chang Tse W.
Fung Michael S. C.
Sun Bill N. C.
Sun Cecily R. Y.
Feisee Lila
Lacey David L.
Mirabel Eric P.
Tanox Biosystems, Inc.
LandOfFree
Antibodies which target a neutralization site within the second does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies which target a neutralization site within the second , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies which target a neutralization site within the second will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2095145